Dana Zakalik

3PUBLICATIONS
19CO-AUTHORS
Cancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 28, 2026
Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2.

Adriana I Apostol, Jacek Gronwald, Cezary Cybulski

|Jan 07, 2022
Q and A: A New Standard of Care for Germline BRCA1 and/or BRCA2 Mutation Carriers With Early-Stage Breast Cancer.

Neelam V Desai, Dana Zakalik, Mark R Somerfield

|Aug 03, 2021
Adjuvant PARP Inhibitors in Patients With High-Risk Early-Stage HER2-Negative Breast Cancer and Germline BRCA Mutations: ASCO Hereditary Breast Cancer Guideline Rapid Recommendation Update.

Nadine M Tung, Dana Zakalik, Mark R Somerfield

Pageof 1